Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lanier

Showing results (371-380 of 609) with videos related to

Pageof 61
Sort By:
The Journal of Experimental Medicine|December 4, 2002
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognitionJakob Michaëlsson, Cristina Teixeira de Matos, Adnane Achour, et al.
Hybridoma|January 1, 1982
Monoclonal antibodies against rat immunoglobulin kappa chainsL L Lanier, G A Gutman, D E Lewis, et al.
Nature Immunology|November 7, 2006
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifsAttila Mócsai, Clare L Abram, Zoltán Jakus, et al.
Applied Neurophysiology|January 1, 1987
Sedation for stereotactic headframe application: a randomized comparison of two techniquesW L Lanier, G J Hool, R J Faust, et al.
Mayo Clinic Proceedings|July 7, 2012
Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and preventionKeith H Berge, Kevin R Dillon, Karen M Sikkink, et al.
Expert Opinion on Drug Delivery|July 1, 2020
Commercialization challenges for drug eluting contact lensesOlivia L Lanier, Keith G Christopher, Russell M Macoon, et al.
Nature|November 4, 1993
B70 antigen is a second ligand for CTLA-4 and CD28M Azuma, D Ito, H Yagita, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptorDavid B Rosen, Jayaram Bettadapura, Mohammed Alsharifi, et al.
The Journal of Experimental Medicine|January 13, 2016
Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricideSharline Madera, Moritz Rapp, Matthew A Firth, et al.
AAPS Pharmscitech|March 15, 2021
Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop FormulationsOlivia L Lanier, Miranda G Manfre, Claire Bailey, et al.
Pageof 61

Showing results (371-380 of 609) with videos related to

Sort By:
Pageof 61
The Journal of Experimental Medicine|December 4, 2002
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognitionJakob Michaëlsson, Cristina Teixeira de Matos, Adnane Achour, et al.
Hybridoma|January 1, 1982
Monoclonal antibodies against rat immunoglobulin kappa chainsL L Lanier, G A Gutman, D E Lewis, et al.
Nature Immunology|November 7, 2006
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifsAttila Mócsai, Clare L Abram, Zoltán Jakus, et al.
Applied Neurophysiology|January 1, 1987
Sedation for stereotactic headframe application: a randomized comparison of two techniquesW L Lanier, G J Hool, R J Faust, et al.
Mayo Clinic Proceedings|July 7, 2012
Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and preventionKeith H Berge, Kevin R Dillon, Karen M Sikkink, et al.
Expert Opinion on Drug Delivery|July 1, 2020
Commercialization challenges for drug eluting contact lensesOlivia L Lanier, Keith G Christopher, Russell M Macoon, et al.
Nature|November 4, 1993
B70 antigen is a second ligand for CTLA-4 and CD28M Azuma, D Ito, H Yagita, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptorDavid B Rosen, Jayaram Bettadapura, Mohammed Alsharifi, et al.
The Journal of Experimental Medicine|January 13, 2016
Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricideSharline Madera, Moritz Rapp, Matthew A Firth, et al.
AAPS Pharmscitech|March 15, 2021
Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop FormulationsOlivia L Lanier, Miranda G Manfre, Claire Bailey, et al.
Pageof 61